85
Participants
Start Date
November 30, 2011
Primary Completion Date
December 31, 2012
Study Completion Date
April 30, 2013
Varenicline
0.5-2 mg per day, oral use
Placebo
1-2 tablets per day, oral use
Nicorette TX
10-15 mg per day, transdermal use (patches)
University Medical Center, Göttingen
University Medical Center Goettingen
OTHER
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
OTHER